サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606473

AIベースの疾病診断市場：コンポーネントタイプ別、診断タイプ別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

AI-based Disease Diagnosis Market, By Component Type, By Diagnosis Type, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
AIベースの疾病診断市場：コンポーネントタイプ別、診断タイプ別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

AIベースの疾病診断市場は、2023年に13億5,450万米ドルに達し、2024年～2032年のCAGRは24.20％で拡大すると予測されます。

さらに、疾病診断におけるAIは、世界のヘルスケアシステムで急速に普及している個別化治療をサポートすることができます。従来のヘルスケア・インフラに対する需要の高まりは、予測期間中にAIベースの疾病診断市場に大きな成長の勢いをもたらすと予想されます。しかし、技術の構築と導入にかかるコストが高いため、市場の成長率に影響を与える可能性があります。

AIベースの疾病診断市場 - 市場力学

世界の患者数の増加とヘルスケアインフラの悪化

世界の患者数の増加が、AIベースの疾病診断市場の成長を促進すると予測されます。医療を必要とする人々の増加は、現在のヘルスケアシステムに大きな負担をかけています。診断センター、医療従事者、施設の不在や医療費の高騰により、多くの人々が質の高い医療を受けられずにいます。ある市場調査によると、アフリカでは人口1万人に対して医師は1人です。先進諸国や世界の他の地域も同様の数字です。さらに、2019年の世界経済フォーラムの調査では、裕福な国における医療の質の不十分さが年間600万人以上の死亡を引き起こしていると主張しています。また、患者数は年々増加しています。患者数の増加は、薬剤耐性疾患株の発生、人口の高齢化、自己免疫疾患患者の増加に起因しています。既存のヘルスケアシステムは、疾病診断に人工知能を活用することで、患者の進化する要求や需要によりよく応えることができます。

AIベースの疾病診断市場 - 主要インサイト

調査アナリストの分析によると、世界市場は2024-2032年の予測期間中に約24.20%のCAGRで拡大すると予測されています。

ソフトウェアカテゴリは、コンポーネントタイプに基づいて2023年に最大の市場シェアを占めると予測されました。

2023年には、診断タイプに基づく放射線診断カテゴリーが最大の市場シェアを占めると予測されました。

2023年の地域別収益シェアは北米が最大でした。

AIベースの疾病診断市場 - セグメンテーション分析：

世界のAIベースの疾病診断市場は、コンポーネントタイプ、診断タイプ、地域に区分されます。

市場は、コンポーネントタイプに基づいて、ソフトウェア、サービス、ハードウェアの3つのセグメントに分けられます。2023年には、ソフトウェア・セグメントが最も大きな収益をもたらしました。AI診断の主要コンポーネントは、ソフトウェアプラットフォームに統合された複雑なアルゴリズムと機械学習モデルです。これらのプラットフォームは、画像データやゲノムデータを含む複雑な医療データを評価し、有用な洞察を提供するため、ソフトウェアはAI主導型診断の基礎となります。ヘルスケア従事者は、新しい機能、アルゴリズム、能力を備えたソフトウェアを継続的に更新・改善することで、診断技術の最先端を維持することができます。AI診断の急速な発展により、この柔軟性と拡張性が不可欠となっています。

診断タイプ別に見ると、市場は心臓病学、腫瘍学、放射線学、胸部・肺、神経学、病理学、その他に区分されます。2023年、収益シェアで市場をリードするのは放射線診断分野です。放射線学では、CT、MRI、超音波、X線から得られる膨大な医療画像を分析します。AIツールはこれらの画像の処理と解読に非常に優れているため、放射線科はAIを統合するのに最適な場所です。AIの迅速かつ正確な画像解析は、診断効果を大幅に向上させ、普及の火付け役となりました。AI が最初に使用された医療専門分野の 1 つは放射線医学、特に画像の解釈と認識でした。AIが放射線科で初めて使用されて以来、より洗練された高度なAI技術が開発されてきました。現在では、ヘルスケア機関で広く使用され、信頼されているため、業界の繁栄に役立っています。

AIベースの疾病診断市場 - 地理的洞察

AIベースの疾病診断市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに広く分布しています。これらの地域は、ビジネスを提供する国に基づいてさらに分けられます。

北米は2023年にAIベースの疾病診断の世界市場をリードしました。高度に発達し、技術的に高度な医療インフラを持つ米国は、北米で最も力のある国であることが大きな要因です。患者の治療や疾病診断に新技術を活用することに関しては、米国がリードしてきました。さらに、AIを活用したテクノロジーと、臨床医療現場での実用的な実装との間に生じるズレを特定する能力を開発することが、取り組みの焦点となります。医療従事者だけでなく患者も、こうした改善から恩恵を受けると思われます。

AIベースの疾病診断市場は、アジア太平洋地域が第2位の収益源になると予想されます。この地域は、地元の医療機関への負担の増大、投資、AI 技術の発展の結果として拡大するでしょう。内視鏡のトップメーカーの一つであるオリンパスは2024年7月、AIを活用して診断プラットフォーム市場に参入すると発表しました。同プラットフォームを病院の内視鏡と連携させるクラウドベースのサービスを利用し、アジア太平洋地域でパイロットプロジェクトを導入します。

AIベースの疾病診断市場 - 競合情勢：

AIベースの疾病診断市場には、Babylon Health、Tempus、Arterys、IBM Watson Health、Insilico Medicine、Zebra Medical Visionなど複数の主要競合企業が存在し、技術革新と戦略的提携が優先されています。企業は、患者の転帰や疾病動向に関するより深い知識を提供するAIを活用した分析プラットフォームに資金を投じています。また、より正確で迅速かつ正確な結果を提供するため、AIを現在のインフラや医療用画像処理機能と統合することが重視されるようになっています。さらに、デジタル企業とヘルスケア・プロバイダーとのコラボレーションが拡大し、イノベーションに拍車がかかり、さまざまなヘルスケア分野でAIツールやソリューションの利用が広がっています。

目次

第1章 AIベースの疾病診断市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 AIベースの疾病診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 AIベースの疾病診断産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 AIベースの疾病診断市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 AIベースの疾病診断市場情勢

  • AIベースの疾患診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 AIベースの疾病診断市場：コンポーネントタイプ別

  • 概要
    • コンポーネントタイプ別セグメントシェア分析
    • ソフトウェア
    • サービス
    • ハードウェア

第8章 AIベースの疾病診断市場：診断タイプ別

  • 概要
    • 診断タイプ別セグメントシェア分析
    • 心臓病学
    • 腫瘍学
    • 放射線科
    • 胸部・肺
    • 神経学
    • 病理学
    • その他

第9章 AIベースの疾病診断市場：地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析 - AIベースの疾病診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Babylon Health
    • Tempus
    • Arterys
    • IBM Watson Health
    • Insilico Medicine
    • Zebra Medical Vision
    • PathAI
    • Buoy Health
    • Freenome
    • Lunit
    • Viz.ai
    • Aidoc
    • Butterfly Network
    • CureMetrix
    • Qure.ai.
    • Others

第11章 アナリストの全方位展望

目次
Product Code: ANV4269

REPORT HIGHLIGHT

The market for AI-based Disease Diagnosis was projected to reach USD 1,354.5 million in 2023 and expand at a CAGR of 24.20% between 2024 - 2032.

The employment of artificial intelligence (AI) technology in the healthcare sector during the disease diagnosis stage is known as AI-based disease diagnosis. Demand for and investment in AI in healthcare has been rising quickly across all industries. The trend is fueled by a number of benefits that AI technology provides. Recently, artificial intelligence has drawn interest from all across the world. In order to duplicate human intelligence, the technology makes use of a number of cutting-edge technologies. Medical picture analysis, disease prediction, and condition detection are just a few of the advanced jobs that AI allows machines to accomplish.

Additionally, AI in disease detection can support individualized treatment, which is rapidly gaining popularity in the world's healthcare system. The growing demand for conventional healthcare infrastructure is anticipated to generate significant growth momentum for the AI-based disease diagnosis market during the projected period. However, the high cost of creating and implementing the technology may affect the rate of market growth.

AI-based Disease Diagnosis Market- Market Dynamics

Growing Number of Patients Worldwide, as well as the Deteriorating Healthcare Infrastructure

The growing number of patients worldwide is anticipated to fuel growth in the market for AI-based disease diagnostics. The growing number of people in need of medical care is putting a great deal of strain on the current healthcare system. Many people lack access to high-quality medical treatment as a result of the absence of diagnostic centers, healthcare practitioners, and facilities, as well as the rising cost of healthcare. According to a market survey, there is one doctor for every 10,000 people in Africa. Developed countries, as well as other parts of the world, have similar figures. Moreover, a 2019 World Economic Forum research claims that the inadequate quality of healthcare in wealthy countries causes over 6 million deaths annually. In addition, the number of patients has been increasing annually. The rise in the number of patients is ascribed to the development of drug-resistant disease strains, the aging of the population, and the growing number of autoimmune disease patients. The existing healthcare system can better meet the evolving requirements and demands of patients by utilizing artificial intelligence in disease diagnostics.

AI-based Disease Diagnosis Market- Key Insights

According to our research analyst's analysis, the global market is projected to expand at a CAGR of approximately 24.20% during the forecast period of 2024-2032.

The software category was predicted to hold the largest market share in 2023 based on component type.

The radiology category was predicted to hold the largest market share in 2023 based on diagnosis type.

North America held the largest revenue share by region in 2023.

AI-based Disease Diagnosis Market- Segmentation Analysis:

The Global AI-based Disease Diagnosis Market is segmented into Component Type, Diagnosis Type, and Region.

The market is divided into three segments based on the component type: software, services, and hardware. In 2023, the software segment brought in the most money. The main components of AI diagnostics are complex algorithms and machine learning models that are integrated into software platforms. Software is the foundation of AI-driven diagnostics since these platforms evaluate intricate medical data, including imaging and genomic data, and offer useful insights. Healthcare practitioners can stay on the cutting edge of diagnostic technology by continually updating and improving software with new features, algorithms, and capabilities. The quick development of AI diagnostics has made this flexibility and scalability essential.

In terms of diagnosis type, the market is segmented into Cardiology, Oncology, Radiology, Chest & Lung, Neurology, Pathology, and Others. In 2023, the market leader in terms of revenue share was the radiology segment. The study of radiology entails analyzing vast amounts of medical pictures from CT, MRI, ultrasound, and X-rays. Because AI tools are so good at processing and deciphering these images, radiology is a great place to integrate AI. AI's rapid and precise picture analysis has greatly increased diagnostic effectiveness and sparked widespread use. One of the first medical specialties to use AI was radiology, namely in picture interpretation and recognition. Since AI was first used in radiology, more sophisticated and advanced AI technologies have been developed. They are now extensively used and trusted in healthcare institutions, which has helped the industry flourish.

AI-based Disease Diagnosis Market- Geographical Insights

The AI-based Disease Diagnosis market is widely distributed geographically in North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further separated based on the countries that provide business.

North America led the global market for AI-based disease diagnosis in 2023. Due in large part to its highly developed and technologically advanced health infrastructure, the United States is the most powerful country in North America. When it comes to using new technologies for patient treatment and disease diagnosis, the US has led the way. Additionally, developing the ability to identify any misalignment between AI-enabled technologies and practical implementations in the clinical care setting will be the focus of the efforts. Patients as well as medical professionals, will benefit from these improvements.

The AI-based disease diagnosis market is expected to see Asia-Pacific become the second-largest revenue generator. The region will increase as a result of the increasing strain on local healthcare organizations, investments, and developments in AI technology. One of the top manufacturers of endoscopes, Olympus, said in July 2024 that it will use AI to enter the diagnostic platform market. With the use of a cloud-based service that links the platform to hospital endoscopes, the pilot project will be introduced in Asia Pacific.

AI-based Disease Diagnosis Market- Competitive Landscape:

Several major competitors, such as Babylon Health, Tempus, Arterys, IBM Watson Health, Insilico Medicine, and Zebra Medical Vision, among others, are present in the AI-based disease diagnosis market, and technological innovation and strategic alliances are prioritized. Businesses are spending money on analytics platforms powered by AI that offer more in-depth knowledge about patient outcomes and illness trends. In order to provide more accurate, quick, and exact results, there is also an increasing emphasis on integrating AI with current infrastructure and medical imaging capabilities. Additionally, collaborations between digital companies and healthcare providers are growing, spurring innovation and broadening the use of AI tools and solutions in a range of healthcare fields.

Recent Developments:

June 2024: The new AI-powered patient management system from Aidoc, which increases clinic throughput and advances patient care, was just released. It is anticipated that this launch will improve the company's standing in the marketplace and allow it to grow its clientele.

June 2024: AliveCor declared that the Kardia 12L ECG System and its KAI 12L AI technology had received FDA approval and would be going on sale. The company's sales prospects are anticipated to improve in the near future as a result of this approval.

April 2024: MindSculpt Analytics and Happiest Mind Technologies Limited announced their collaboration. With an emphasis on personal health and wellness, the new partnership seeks to provide cutting-edge medical diagnostic solutions by utilizing artificial intelligence and machine learning technology.

SCOPE OF THE REPORT

The scope of this report covers the AI-based Disease Diagnosis market by its major segments, which include as follows:

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Babylon Health
  • Tempus
  • Arterys
  • IBM Watson Health
  • Insilico Medicine
  • Zebra Medical Vision
  • PathAI
  • Buoy Health
  • Freenome
  • Lunit
  • Viz.ai
  • Aidoc
  • Butterfly Network
  • CureMetrix
  • Qure.ai.
  • Others

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY COMPONENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cardiology
  • Oncology
  • Radiology
  • Chest & Lung
  • Neurology
  • Pathology
  • Others

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI-based Disease Diagnosis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Disease Diagnosis Market Snippet by Component Type
    • 2.1.2. AI-based Disease Diagnosis Market Snippet by Diagnosis Type
    • 2.1.3. AI-based Disease Diagnosis Market Snippet by Country
    • 2.1.4. AI-based Disease Diagnosis Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Disease Diagnosis Key Market Trends

  • 3.1. AI-based Disease Diagnosis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Disease Diagnosis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Disease Diagnosis Market Opportunities
  • 3.4. AI-based Disease Diagnosis Market Future Trends

4. AI-based Disease Diagnosis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Disease Diagnosis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Disease Diagnosis Market Landscape

  • 6.1. AI-based Disease Diagnosis Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Disease Diagnosis Market - By Component Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component Type, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services
    • 7.1.4. Hardware

8. AI-based Disease Diagnosis Market - By Diagnosis Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis Type, 2023 & 2032 (%)
    • 8.1.2. Cardiology
    • 8.1.3. Oncology
    • 8.1.4. Radiology
    • 8.1.5. Chest & Lung
    • 8.1.6. Neurology
    • 8.1.7. Pathology
    • 8.1.8. Others

9. AI-based Disease Diagnosis Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. AI-based Disease Diagnosis Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. AI-based Disease Diagnosis Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. AI-based Disease Diagnosis Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. AI-based Disease Diagnosis Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. AI-based Disease Diagnosis Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- AI-based Disease Diagnosis Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Babylon Health
    • 10.2.2. Tempus
    • 10.2.3. Arterys
    • 10.2.4. IBM Watson Health
    • 10.2.5. Insilico Medicine
    • 10.2.6. Zebra Medical Vision
    • 10.2.7. PathAI
    • 10.2.8. Buoy Health
    • 10.2.9. Freenome
    • 10.2.10. Lunit
    • 10.2.11. Viz.ai
    • 10.2.12. Aidoc
    • 10.2.13. Butterfly Network
    • 10.2.14. CureMetrix
    • 10.2.15. Qure.ai.
    • 10.2.16. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us